• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫抑制相关疾病患者肺泡型棘球蚴病的特征与临床病程:一项回顾性队列研究

Characteristics and Clinical Course of Alveolar Echinococcosis in Patients with Immunosuppression-Associated Conditions: A Retrospective Cohort Study.

作者信息

Deibel Ansgar, Meyer Zu Schwabedissen Cordula, Husmann Lars, Grimm Felix, Deplazes Peter, Reiner Cäcilia S, Müllhaupt Beat

机构信息

Department of Gastroenterology and Hepatology, University Hospital Zurich, 8091 Zurich, Switzerland.

Department of Nuclear Medicine, University Hospital Zurich, 8091 Zurich, Switzerland.

出版信息

Pathogens. 2022 Apr 6;11(4):441. doi: 10.3390/pathogens11040441.

DOI:10.3390/pathogens11040441
PMID:35456117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032794/
Abstract

OBJECTIVES

Since the change in the millennium, an increase in cases of alveolar echinococcosis (AE) has been observed in endemic European countries. Previous studies indicate that a significant proportion of the new AE cases have an immunosuppression-associated condition (IAC). The aim of the current study was to determine how IACs impact the number of new AE diagnoses per year and the characteristics of AE at diagnosis and its clinical course at our center.

METHODS

Retrospective analysis of 189 patients with AE diagnosed between 2000 and 2021 and participating in the Zurich Echinococcosis Cohort Study (ZECS) included clinical characteristics of AE at diagnosis and report of an IAC, as well as the clinical course during follow-up.

RESULTS

Of 189 patients participating in this study, 38 had an IAC reported at, or shortly after, AE diagnosis. Over time, there was a steeper increase in the number of newly diagnosed AE patients without an IAC than the number of patients with IAC. Patients with an IAC were older at diagnosis, more frequently had an incidental finding of AE, smaller mean lesion size, and negative Em18 serology. All but two showed favorable outcomes on the last follow-up.

CONCLUSION

IACs have little impact on the increase in new AE cases, as well as on the extent of the disease at diagnosis and clinical course.

摘要

目的

自千禧年以来,欧洲流行国家的肺泡型棘球蚴病(AE)病例有所增加。先前的研究表明,相当一部分新的AE病例患有免疫抑制相关疾病(IAC)。本研究的目的是确定IAC如何影响我们中心每年新诊断的AE病例数、诊断时AE的特征及其临床病程。

方法

对2000年至2021年间诊断为AE并参与苏黎世棘球蚴病队列研究(ZECS)的189例患者进行回顾性分析,包括诊断时AE的临床特征、IAC报告以及随访期间的临床病程。

结果

在参与本研究的189例患者中,38例在AE诊断时或诊断后不久报告有IAC。随着时间的推移,新诊断的无IAC的AE患者数量比有IAC的患者数量增长得更快。有IAC的患者诊断时年龄较大,更常因偶然发现而诊断为AE,平均病变大小较小,Em18血清学检测为阴性。除两名患者外,所有患者在最后一次随访时均显示良好预后。

结论

IAC对新AE病例的增加以及诊断时疾病的程度和临床病程影响不大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/9032794/36cc1b7f4f92/pathogens-11-00441-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/9032794/b6b804354648/pathogens-11-00441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/9032794/36cc1b7f4f92/pathogens-11-00441-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/9032794/b6b804354648/pathogens-11-00441-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/64e3/9032794/36cc1b7f4f92/pathogens-11-00441-g002.jpg

相似文献

1
Characteristics and Clinical Course of Alveolar Echinococcosis in Patients with Immunosuppression-Associated Conditions: A Retrospective Cohort Study.免疫抑制相关疾病患者肺泡型棘球蚴病的特征与临床病程:一项回顾性队列研究
Pathogens. 2022 Apr 6;11(4):441. doi: 10.3390/pathogens11040441.
2
Development of Em18-immunoblot and Em18-ELISA for specific diagnosis of alveolar echinococcosis.用于泡型包虫病特异性诊断的Em18免疫印迹法和Em18酶联免疫吸附测定法的开发。
Acta Trop. 2003 Feb;85(2):173-82. doi: 10.1016/s0001-706x(02)00221-8.
3
Long-term follow-up of liver alveolar echinococcosis using echinococcosis multilocularis ultrasound classification.肝泡型包虫病的超声分类及其长期随访。
World J Gastroenterol. 2021 Oct 28;27(40):6939-6950. doi: 10.3748/wjg.v27.i40.6939.
4
Elevated incidence of alveolar echinococcosis in immunocompromised patients.免疫功能低下患者肺泡型棘球蚴病发病率升高。
Food Waterborne Parasitol. 2019 May 31;16:e00060. doi: 10.1016/j.fawpar.2019.e00060. eCollection 2019 Sep.
5
Serodiagnosis of alveolar echinococcosis: detection of antibody against EM18 in patients and rodents.肺泡型棘球蚴病的血清学诊断:检测患者和啮齿动物体内抗EM18抗体
Southeast Asian J Trop Med Public Health. 1997;28 Suppl 1:117-24.
6
Increased incidence and characteristics of alveolar echinococcosis in patients with immunosuppression-associated conditions.免疫抑制相关疾病患者中肺包虫病的发病率及特征增加。
Clin Infect Dis. 2014 Oct 15;59(8):1095-104. doi: 10.1093/cid/ciu520. Epub 2014 Jul 16.
7
Frequency and clinical presentation of alveolar and cystic echinococcosis in a tertiary medical center in Germany 2004-2018: lessons from a low-prevalence area.2004 - 2018年德国一家三级医疗中心肺泡型和囊型棘球蚴病的发病率及临床表现:来自低流行地区的经验教训
Z Gastroenterol. 2019 Nov;57(11):1281-1290. doi: 10.1055/a-1013-4405. Epub 2019 Nov 18.
8
Evaluation of an enzyme-linked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: results of a blind test.采用亲和纯化的Em18酶联免疫吸附测定(ELISA)和重组Em18 ELISA对肺泡型棘球蚴病进行鉴别诊断的评估:盲法检测结果
J Clin Microbiol. 2002 Nov;40(11):4161-5. doi: 10.1128/JCM.40.11.4161-4165.2002.
9
Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis.评估泡型包虫病的肝内表现和肝外远处疾病。
World J Gastroenterol. 2020 Aug 7;26(29):4302-4315. doi: 10.3748/wjg.v26.i29.4302.
10
Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis.重组Em18-ELISA在评估肺泡型棘球蚴病患者治疗效果中的应用价值。
J Gastroenterol. 2005 Apr;40(4):426-31. doi: 10.1007/s00535-004-1559-7.

引用本文的文献

1
Epidemiological and clinical characteristics of patients in the alveolar echinococcosis registry, France, 1982 to 2021.1982年至2021年法国肺泡型棘球蚴病登记患者的流行病学和临床特征
Euro Surveill. 2025 Aug;30(32). doi: 10.2807/1560-7917.ES.2025.30.32.2500041.
2
Comprehensive Survival Analysis of Alveolar Echinococcosis Patients, University Hospital Zurich, Zurich, Switzerland, 1973-2022.1973年至2022年瑞士苏黎世大学医院肺泡型棘球蚴病患者的综合生存分析
Emerg Infect Dis. 2025 May;31(5):906-916. doi: 10.3201/eid3105.241608.
3
Human cystic echinococcosis: first molecular identification of Echinococcus canadensis G7 in Brazil.

本文引用的文献

1
Evaluation of Serological Markers in Alveolar Echinococcosis Emphasizing the Correlation of PET-CTI Tracer Uptake with RecEm18 and -Specific IgG.肺泡型棘球蚴病血清学标志物的评估:着重探讨PET-CT示踪剂摄取与重组Em18及特异性IgG的相关性
Pathogens. 2022 Feb 12;11(2):239. doi: 10.3390/pathogens11020239.
2
Evaluation of a structured treatment discontinuation in patients with inoperable alveolar echinococcosis on long-term benzimidazole therapy: A retrospective cohort study.评价长期苯并咪唑治疗无法手术的泡型包虫病患者中结构化治疗停药的效果:一项回顾性队列研究。
PLoS Negl Trop Dis. 2022 Jan 28;16(1):e0010146. doi: 10.1371/journal.pntd.0010146. eCollection 2022 Jan.
3
人囊性包虫病:在巴西首次鉴定出加拿大棘球绦虫 G7 。
Parasitol Res. 2024 Jun 11;123(6):239. doi: 10.1007/s00436-024-08262-6.
4
Real-time multiplex PCR for human echinococcosis and differential diagnosis.实时多重 PCR 用于人类包虫病和鉴别诊断。
Parasite. 2023;30:3. doi: 10.1051/parasite/2023003. Epub 2023 Jan 25.
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?
泡型包虫病:在北美、中欧和亚洲,是什么引发了其出现?
Curr Opin Infect Dis. 2021 Oct 1;34(5):440-446. doi: 10.1097/QCO.0000000000000765.
4
Hepatic Alveolar Echinococcosis.肝泡型包虫病。
Semin Liver Dis. 2021 Aug;41(3):393-408. doi: 10.1055/s-0041-1730925. Epub 2021 Jun 23.
5
Agranulocytosis leads to intestinal oncosphere invasion and hepatic metacestode development in naturally resistant Wistar rats.粒细胞缺乏症导致天然抗性 Wistar 大鼠肠道细颈囊尾蚴侵入和肝包虫发育。
Parasitology. 2021 Jan;148(1):53-62. doi: 10.1017/S0031182020002012. Epub 2020 Oct 22.
6
Spatial distribution and incidence trend of human alveolar echinococcosis in southwest Germany: increased incidence and urbanization of the disease?德国西南部人体细粒棘球蚴病的空间分布和发病趋势:发病率上升和疾病的城市化?
Infection. 2020 Dec;48(6):923-927. doi: 10.1007/s15010-020-01479-4. Epub 2020 Jul 16.
7
Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study.血管炎患者严重感染的流行病学、时间趋势和结局:一项长达 19 年的全国性研究。
Arthritis Care Res (Hoboken). 2021 Oct;73(10):1544-1551. doi: 10.1002/acr.24348. Epub 2021 Aug 26.
8
Elevated incidence of alveolar echinococcosis in immunocompromised patients.免疫功能低下患者肺泡型棘球蚴病发病率升高。
Food Waterborne Parasitol. 2019 May 31;16:e00060. doi: 10.1016/j.fawpar.2019.e00060. eCollection 2019 Sep.
9
Comparing the burdens of opportunistic infections among patients with systemic rheumatic diseases: a nationally representative cohort study.比较系统性风湿病患者的机会性感染负担:一项全国代表性队列研究。
Arthritis Res Ther. 2019 Oct 12;21(1):211. doi: 10.1186/s13075-019-1997-5.
10
Immune Dysfunction and Risk of Infection in Chronic Kidney Disease.慢性肾脏病患者的免疫功能障碍与感染风险。
Adv Chronic Kidney Dis. 2019 Jan;26(1):8-15. doi: 10.1053/j.ackd.2019.01.004.